Adlai Nortye Ltd American Depositary Shares (ANL)

May 23, 2024, 9:03 PM EDT - 8 months ago

Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024

May 22, 2024, 8:00 AM EDT - 8 months ago

Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy

Mar 29, 2024, 6:00 AM EDT - 10 months ago

Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development

Nov 17, 2023, 7:30 AM EST - 1 year ago

Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC

Oct 23, 2023, 8:12 AM EDT - 1 year ago

Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award

Oct 13, 2023, 8:00 AM EDT - 1 year ago

Adlai Nortye Dives In Nasdaq Debut, As Key Product Faces Hurdles

Oct 3, 2023, 12:05 PM EDT - 1 year ago

Adlai Nortye Ltd. Announces Closing of Initial Public Offering

Sep 30, 2023, 3:30 AM EDT - 1 year ago

U.S. IPO Weekly Recap: Holdover Adlai Nortye Leads 4 IPO Week As More Small Deals Enter The Pipeline

BIRK KHIW LRE VSME

Sep 29, 2023, 2:46 AM EDT - 1 year ago

Adlai Nortye Ltd. Announces Pricing of Initial Public Offering

Sep 3, 2023, 10:45 AM EDT - 1 year ago

U.S. IPO Weekly Recap: August Wraps Up With 1 Nano-Cap

ABNB ARM CART IPO IPOS IVP SNOW

Aug 12, 2023, 6:00 AM EDT - 1 year ago

U.S. IPO Weekly Recap: IPO Market Sees Fitness, Liquor Marketing, And Medical Devices

FTEL NRXS NWGL VFS

Aug 11, 2023, 2:16 PM EDT - 1 year ago

IPO Update: Adlai Nortye Readies $72 Million U.S. IPO

Aug 11, 2023, 7:05 AM EDT - 1 year ago

Cancer treatment company Adlai Nortye sets terms in IPO

Jul 31, 2023, 6:17 PM EDT - 1 year ago

Adlai Nortye Ltd. Begins U.S. IPO Rollout